| Literature DB >> 34294054 |
Jong-Hoon Kim1, Ha-Neul Lee1, Seong-Kyeong Bae1, Dong-Ha Shin2, Bon-Hwan Ku2, Ho-Yong Park3, Tae-Sook Jeong4.
Abstract
BACKGROUND: The importance of efficient denture deposit removal and oral hygiene has been further underscored by the continuous increase of denture wearers. Denture hygiene management has also become an important aspect associated with denture-induced stomatitis. This study aims to evaluate the denture cleaning effect of arazyme, the metalloprotease produced from the Serratia proteamaculans HY-3. We performed growth inhibition tests against oral opportunistic pathogens to be used as a potential oral health care agent.Entities:
Keywords: Antimicrobial activity; Arazyme; Denture cleansers; Denture hygiene; Protease
Mesh:
Substances:
Year: 2021 PMID: 34294054 PMCID: PMC8299675 DOI: 10.1186/s12903-021-01733-7
Source DB: PubMed Journal: BMC Oral Health ISSN: 1472-6831 Impact factor: 3.747
Stability of arazyme in the presence of various detergent components
| Detergent components | Concentration (v/v, %) | Residual activity (%) | |
|---|---|---|---|
| Arazyme | Everlase 6.0T | ||
| None | – | 100 | 100 |
| Surfactant | |||
| SDS | 25 | 107 | 104 |
| Bleaching agents | |||
| Sodium bicarbonate | 25 | 110 | 103 |
| Sodium perborate | 25 | 97 | 110 |
| Sodium percarbonate | 25 | 105 | 99 |
| TAED | 25 | 92 | 90 |
| pH adjustment | |||
| Citric acid | 2 | 98 | 91 |
| Non-chlorine oxidizer | |||
| Potassium peroxymonosulfate | 25 | 103 | 98 |
| Anti-redeposition agent | |||
| PEG | 2 | 100 | 100 |
SDS sodium dodecyl sulfate, TAED tetraacetylethylenediamine, PEG polyethylene glycol
Data are presented as means (n = 3)
Fig. 1SDS-PAGE profiled a of purified arazyme from S. proteamaculans HY-3 and comparison of proteolytic activity with Everlase 6.0T used in denture cleanser (b). The purified enzyme was loaded on a 12% SDS polyacrylamide gel and stained with Coomassie brilliant blue. Lane M: molecular weight marker; Lane 1: extracellular fraction of S. proteamaculans HY-3; Lane 2: purified arazyme. Data are presented as means ± SD (n = 3). * Indicates by P < 0.05 versus the Everlase 6.0T
Fig. 2a Effect of temperature on the proteolytic activity. The temperature profiles of proteolytic activity treated with each protease were determined at temperature between 20 and 100 °C. b Effect of pH on the activity of arazyme and Everlase 6.0T. The proteolytic activities were assayed in the pH range of 5 to 10 using buffers of different pH values. Data are presented as means ± SD (n = 3)
Wash performance of arazyme, everlase 6.0T, and Polident® at 25 °C
| EMPA cottons | Samples | L* | a* | b* | K/S value | Color |
|---|---|---|---|---|---|---|
| Blood | Water | 58.95 ± 0.25a | 8.56 ± 0.46a | 20.35 ± 0.23a | 1.20 ± 0.15b |
|
| Arazyme (220 μg) | 51.87 ± 0.37c | 3.74 ± 0.53b | 17.73 ± 0.65c | 0.89 ± 0.13c |
| |
| Everlase 6.0T (13.75 mg) | 55.83 ± 0.67b | 8.84 ± 0.63a | 19.67 ± 0.27b | 1.50 ± 0.17a |
| |
| Polident® (1 tablet) | 50.73 ± 0.54 cd | 2.29 ± 0.43c | 15.34 ± 0.36d | 0.46 ± 0.09d |
| |
| Cocoa | Water | 62.05 ± 0.34a | 4.44 ± 0.26a | 18.12 ± 0.19a | 4.47 ± 0.14a |
|
| Arazyme (220 μg) | 59.68 ± 0.33b | 1.35 ± 0.21c | 15.75 ± 0.34b | 2.42 ± 0.21c |
| |
| Everlase 6.0T (13.75 mg) | 60.13 ± 0.23b | 3.84 ± 0.33b | 18.02 ± 0.27a | 3.89 ± 0.37b |
| |
| Polident® (1 tablet) | 58.89 ± 0.18c | 3.36 ± 0.27b | 13.48 ± 0.31c | 0.57 ± 0.26d |
| |
| Red wine | Water | 77.23 ± 0.35a | 1.35 ± 0.12a | 9.42 ± 0.42a | 0.79 ± 0.11a |
|
| Arazyme (220 μg) | 71.56 ± 0.77d | 1.02 ± 0.17b | 7.23 ± 0.38b | 0.51 ± 0.12c |
| |
| Everlase 6.0T (13.75 mg) | 75.28 ± 0.46b | 1.27 ± 0.09a | 9.38 ± 0.47a | 0.75 ± 0.15b |
| |
| Polident® (1 tablet) | 74.37 ± 0.14c | 0.71 ± 0.13c | 4.73 ± 0.26c | 0.18 ± 0.14d |
|
L* brightness, a* red-green, b* yellow-blue, K/S value: color depth
a−dMean ± SD (n = 3) within columns followed by the different letters indicate a significant difference by Scheffé’s test (P < 0.05). One tablet of Polident is 27,210 mg
Fig. 3Evaluation of the cleaning abilities of arazyme. 220 μg and 13.75 mg of arazyme, 13.75 mg of Everlase 6.0T, and one tablet of Polident® were dissolved in 200 mL of tap water, respectively. The contaminated dentures were soaked in each solution at 25 °C for 1 h. Treated dentures were stained with a 0.05% Coomassie Brilliant Blue R-250 (Bio-Rad, USA) reagent and subsequently rinsed in tap water to remove any unbound dye. The experiments were performed in triplicate under the same conditions
Normalized staining intensity of artificially contaminated dentures after treatment
| Samples | Treatment condition | Normalized intensity |
|---|---|---|
| Water | – | 137.8 ± 4.8a |
| Arazyme | 220 μg | 115.0 ± 6.6b |
| 13.75 mg | 96.4 ± 4.2c | |
| Everlase 6.0T | 13.75 mg | 125.9 ± 5.2b |
| Polydent® | 2710 mg (1 tablet) | 90.4 ± 0.8d |
a−dMean ± SD (n = 3) within columns followed by the different letters indicate a significant difference by Scheffé’s test (P < 0.05)
Fig. 4Inhibition growth curve of E. faecalis (a), S. epidermis (b), C. albicans (c), and S. mutans (d). To estimate antimicrobial activity, corresponding concentrations (10, 20, 50, 100, and 200 mg/mL) of arazyme were applied to each growth inhibition assay. The treated cells were incubated with shaking, and the optical density at 595 nm of each sample was measured every 3 h for 1 day. Data are presented as means ± SD (n = 3). Statistical significance between compared groups are indicated as * P < 0.05